This article is currently undergoing investigation.
Research Paper Volume 12, Issue 24 pp 25767—25777

Zinc oxide nanoparticles (ZnO NPs) combined with cisplatin and gemcitabine inhibits tumor activity of NSCLC cells


Figure 2. The toxicity of Cp, Gem, Cp+Gem, ZnO-NPs(Cp), ZnO-NPs(Gem) and ZnO NPs(Cp/Gem) on A549 cells is tested by MTT assay. * P< 0.05 vs. Control. # P< 0.05 vs. Cp, Gem, Cp+Gem, ZnO-NPs(Cp), or ZnO-NPs(Gem) groups.